Alpha 2.0
Login Register
» Articles » PMID: 29904717

Measurement Bone Mineral Density (BMD) of Patients with Beta Thalassemia

Overview
Journal Data Brief
Date 2018 Jun 16
PMID 29904717
Citations 4
Authors
Sakineh Abbasi
Jafar Fatahi Asl
Leila Moein Zadeh
Mohammad Mirdoraghi
Affiliations
Soon will be listed here.
Abstract

The aim of the study is determining bone mineral density (BMD) of Patients with beta thalassemia in order to find the prevalence and related factors on the conditions. -Score of femoral neck and lumbar vertebrae were reported comparing normal matched subjects. Age and bone mineral density were significantly correlated. Moreover, the disease had significantly higher severity in men than in women. A negative significant correlation was detected between BMD and the mean of hematocrit in the last 5 years. There was significant differences between sex hormone and bone density. A significant correlation between hydroxy urea and BMD were found. A significant relationship between the use of bisphosphonates and bone density were found. Osteopenia and osteoporosis were highly prevalent in our participants. Therefore, regular tests are required to examine bone mineral density in these patients. Furthermore, the exact effect of age on bone mineral density need to be clarified.

Citing Articles

Using bone mineral apparent density for BMD adjustment in chronic diseases: Thalassemia an example.

Mohajeri-Tehrani M, Gerami H, Shirazi S, Ostadi M, Larijani B, Hamidi Z Caspian J Intern Med. 2024; 15(3):494-498.

PMID: 39011446 PMC: 11246673. DOI: 10.22088/cjim.15.3.494.

Prevalence and risk factors predisposing low bone mineral density in patients with thalassemia.

Ananvutisombat N, Tantiworawit A, Punnachet T, Hantrakun N, Piriyakhuntorn P, Rattanathammethee T Front Endocrinol (Lausanne). 2024; 15:1393865.

PMID: 38978629 PMC: 11228236. DOI: 10.3389/fendo.2024.1393865.

New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.

Carsote M, Vasiliu C, Trandafir A, Albu S, Dumitrascu M, Popa A Diagnostics (Basel). 2022; 12(8).

PMID: 36010271 PMC: 9406368. DOI: 10.3390/diagnostics12081921.

Bone Mineral Density, Serum Calcium, and Vitamin D Levels in Adult Thalassemia Major Patients: Experience From a Single Center in Eastern India.

Santra S, Sharma K, Dash I, Mondal S, Mondal H Cureus. 2022; 14(7):e26688.

PMID: 35959170 PMC: 9359209. DOI: 10.7759/cureus.26688.

References
1.
Nakavachara P, Petchkul J, Jeerawongpanich K, Kiattisakthavee P, Manpayak T, Netsakulnee P . Prevalence of low bone mass among adolescents with nontransfusion-dependent hemoglobin E/β-thalassemia and its relationship with anemia severity. Pediatr Blood Cancer. 2017; 65(1). DOI: 10.1002/pbc.26744. View
2.
Atteritano M, Sorbara S, Bagnato G, Miceli G, Sangari D, Morgante S . Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS One. 2013; 8(6):e66991. PMC: 3688576. DOI: 10.1371/journal.pone.0066991. View
3.
Karimi M, Ghiam A, Hashemi A, Alinejad S, Soweid M, Kashef S . Bone mineral density in beta-thalassemia major and intermedia. Indian Pediatr. 2007; 44(1):29-32. View
4.
Anderst W, West T, Donaldson 3rd W, Lee J . Cervical spine bone density in young healthy adults as a function of sex, vertebral level and anatomic location. Eur Spine J. 2017; 26(9):2281-2289. DOI: 10.1007/s00586-017-5119-2. View
5.
Hwang J, Lee E, Ahn J, Cha H, Koh E, Lee J . Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis. Osteoporos Int. 2016; 28(1):231-237. DOI: 10.1007/s00198-016-3703-7. View